TCL Archive Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease December 28, 2012
TCL Archive DeVita Changes Mind On OSP Phase Out Reasons, But Presses for “Internalizing” Coordinating Portfolio January 1, 1988
TCL Archive HCRA Response On DRGs and Clinical Research Threat Called A “Stone Wall,” Legislative Remedy Sought July 27, 1984
TCL Archive Researchers Feel Impact of Shutdown As Grant Review Stops, Funding Runs Dry January 5, 1996
